IRIS Accounts Production v25.1.4.42 10701467 director 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107014672024-03-31107014672025-03-31107014672024-04-012025-03-31107014672023-03-31107014672023-04-012024-03-31107014672024-03-3110701467ns15:EnglandWales2024-04-012025-03-3110701467ns14:PoundSterling2024-04-012025-03-3110701467ns10:Director12024-04-012025-03-3110701467ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110701467ns10:SmallEntities2024-04-012025-03-3110701467ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3110701467ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110701467ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110701467ns10:FullAccounts2024-04-012025-03-3110701467ns10:OrdinaryShareClass12024-04-012025-03-3110701467ns10:RegisteredOffice2024-04-012025-03-3110701467ns5:CurrentFinancialInstruments2025-03-3110701467ns5:CurrentFinancialInstruments2024-03-3110701467ns5:Non-currentFinancialInstruments2025-03-3110701467ns5:Non-currentFinancialInstruments2024-03-3110701467ns5:ShareCapital2025-03-3110701467ns5:ShareCapital2024-03-3110701467ns5:RetainedEarningsAccumulatedLosses2025-03-3110701467ns5:RetainedEarningsAccumulatedLosses2024-03-3110701467ns5:PlantMachinery2024-03-3110701467ns5:FurnitureFittings2024-03-3110701467ns5:MotorVehicles2024-03-3110701467ns5:ComputerEquipment2024-03-3110701467ns5:PlantMachinery2024-04-012025-03-3110701467ns5:FurnitureFittings2024-04-012025-03-3110701467ns5:MotorVehicles2024-04-012025-03-3110701467ns5:ComputerEquipment2024-04-012025-03-3110701467ns5:PlantMachinery2025-03-3110701467ns5:FurnitureFittings2025-03-3110701467ns5:MotorVehicles2025-03-3110701467ns5:ComputerEquipment2025-03-3110701467ns5:PlantMachinery2024-03-3110701467ns5:FurnitureFittings2024-03-3110701467ns5:MotorVehicles2024-03-3110701467ns5:ComputerEquipment2024-03-3110701467ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3110701467ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110701467ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2025-03-3110701467ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-03-3110701467ns5:DeferredTaxation2024-03-3110701467ns5:DeferredTaxation2024-04-012025-03-3110701467ns5:DeferredTaxation2025-03-3110701467ns10:OrdinaryShareClass12025-03-31
REGISTERED NUMBER: 10701467 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

FRANCIS CLINIC LTD

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


FRANCIS CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Miss R K Francis





REGISTERED OFFICE: Ground Floor 16 Gildredge Road
Eastbourne
East Sussex
BN21 4RL





REGISTERED NUMBER: 10701467 (England and Wales)





ACCOUNTANTS: Acuity Professional Partnership LLP
Unit 2.02 High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 48,836 7,235

CURRENT ASSETS
Stocks 4,137 3,546
Debtors 5 19,653 32,741
Cash at bank and in hand 610 7,162
24,400 43,449
CREDITORS
Amounts falling due within one year 6 32,736 42,322
NET CURRENT (LIABILITIES)/ASSETS (8,336 ) 1,127
TOTAL ASSETS LESS CURRENT
LIABILITIES

40,500

8,362

CREDITORS
Amounts falling due after more than one year 7 (36,349 ) (6,393 )

PROVISIONS FOR LIABILITIES 9 (12,209 ) (1,375 )
NET (LIABILITIES)/ASSETS (8,058 ) 594

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings (8,158 ) 494
SHAREHOLDERS' FUNDS (8,058 ) 594

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

BALANCE SHEET - continued
31 MARCH 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 July 2025 and were signed by:





Miss R K Francis - Director


FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Francis Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

REVENUE
Revenue is recognised at the fair value of the consideration received or receivable for medical and beauty
treatments provided in the normal course of business, and is shown net of VAT and other sales related taxes.

TANGIBLE FIXED ASSETS
Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation,
net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings 25% reducing balance
Computers 25% reducing balance
Motor vehicles 25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

STOCKS
Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost
comprises direct materials and, where applicable, direct labour costs and those overheads that have been
incurred in bringing the inventories to their present location and condition.

Inventories held for distribution at no or nominal consideration are measured at the lower of cost and
replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of
inventories over its estimated selling price less costs to complete and sell is recognised as an impairment loss
in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued
DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CASH AND CASH EQUIVALENTS
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with
banks, other short-term liquid investments with original maturities of three months or less, and bank
overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting
estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future
periods.

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

GOING CONCERN
The company's balance sheet shows a net deficit shareholders fund position. However, the director's have received confirmation from the shareholders of their financial support for the foreseeable future and for at least twelve months from the date of signature of these accounts.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 1 ) .

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipment Totals
£    £    £    £    £   
Cost
At 1 April 2024 - 12,401 - 4,954 17,355
Additions 975 896 51,510 892 54,273
At 31 March 2025 975 13,297 51,510 5,846 71,628
Depreciation
At 1 April 2024 - 7,259 - 2,861 10,120
Charge for year 202 1,249 10,648 573 12,672
At 31 March 2025 202 8,508 10,648 3,434 22,792
Net book value
At 31 March 2025 773 4,789 40,862 2,412 48,836
At 31 March 2024 - 5,142 - 2,093 7,235

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors (92 ) 736
Other debtors 19,745 32,005
19,653 32,741

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 8) 24,523 17,723
Trade creditors 2,979 3,330
Taxation and social security 2,342 11,475
Other creditors 2,892 9,794
32,736 42,322

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans (see note 8) 36,349 6,393

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2025 2024
£    £   
Amounts falling due in more than five years:

Repayable by instalments
HP loans more 5 yr by instal 34,517 -

8. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 15,156 13,765
Bank loans 4,571 3,958
HP loans<1 year 4,796 -
24,523 17,723

Amounts falling due between one and two years:
Bank loans - 1-2 years 1,832 6,393

Amounts falling due in more than five years:

Repayable by instalments
HP loans more 5 yr by instal 34,517 -

9. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 12,209 1,375

Deferred
tax
£   
Balance at 1 April 2024 1,375
Provided during year 10,834
Balance at 31 March 2025 12,209

FRANCIS CLINIC LTD (REGISTERED NUMBER: 10701467)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary 1 100 100

11. DIRECTORS' TRANSACTIONS

Dividends totalling £Nil (2024 - £27,500) were paid in the year in respect of shares held by the company's
directors.

Advances or credits have been granted by the company to its directors as follows:

Description

% Rate
Opening
balance
Interest
charged
Amountsdeposi
ted
Closing
balance
£    £    £    £   
Loan to director 2.25 22,853 0 15,992 6,861
22,853 0 15,992 6,861